Aptagen, LLC
NC3S (ID# 8079)
DNA
N‑Cadherin
Protein
20.08 ± 0.72 nM (reported value)
4.5 g L−1 glucose and 5 mM MgCl2 in Dulbecco’s PBS without calcium and magnesium, yeast tRNA and BSA
4, 25, 37°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5’-dTpdTpdGpdCpdApdCpdTpdApdTpdGpdTpdTpdTpdTpdApdGpdCpdTpdApdGpdGpdGpdTpdTpdCpdCpdCpdTpdCpdCpdGpdGpdApdGpdApdTpdApdGpdTpdApdApdGpdTpdGpdCpdApdAp-3’
47
14499.4
454400
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Gao T , Ding P , Li W , Wang Z , Lin Q , Pei R . Isolation of DNA aptamers targeting N-cadherin and high-efficiency capture of circulating tumor cells by using dual aptamers. Nanoscale. 2020 Nov 19;12(44):22574-22585. doi: 10.1039/d0nr06180h. PMID: 33174555.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.